Novagold Resources (AMEX:NG) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.03) by 433.33 percent. This is a 433.33 percent decrease over losses of $(0.03) per share from the same period last year.
Sagimet Biosciences Announces Appointment Of Thierry Chauche As Chief Financial Officer, Effective May 6, 2024
Sagimet Biosciences Inc. ((Sagimet, NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional metabolic and fibrotic pathways, today
